Scarica l'app Stockscreener
32.11
0.93%
-0.30
Dopo l'orario di chiusura:
32.11
Precedente Chiudi:
$32.41
Aprire:
$32.46
Volume 24 ore:
211.07K
Relative Volume:
0.73
Capitalizzazione di mercato:
$1.03B
Reddito:
$566.77M
Utile/perdita netta:
$48.16M
Rapporto P/E:
26.98
EPS:
1.19
Flusso di cassa netto:
$274.29M
1 W Prestazione:
-0.46%
1M Prestazione:
+6.64%
6M Prestazione:
-1.47%
1 anno Prestazione:
-6.55%
Intervallo 1D:
$32.05
$32.66
Intervallo di 1 settimana:
$30.75
$32.66
Portata 52W:
$23.23
$42.29
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Nome
Collegium Pharmaceutical Inc
Settore
Telefono
781-713-3699
Indirizzo
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Confronta COLL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
32.11 | 1.02B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
152.82 | 68.32B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.66 | 46.55B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.85 | 43.80B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.33 | 19.01B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
306.41 | 13.79B | 2.99B | 1.21B | 1.13B | 25.06 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-05-10 | Downgrade | Needham | Buy → Hold |
| 2024-05-10 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Downgrade | Jefferies | Buy → Hold |
| 2023-08-25 | Reiterato | Needham | Buy |
| 2023-05-02 | Ripresa | Jefferies | Buy |
| 2022-08-08 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-14 | Iniziato | BWS Financial | Sell |
| 2020-05-27 | Iniziato | Guggenheim | Neutral |
| 2020-02-19 | Ripresa | Jefferies | Buy |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-05-03 | Ripresa | H.C. Wainwright | Buy |
| 2019-04-12 | Ripresa | Janney | Buy |
| 2019-03-20 | Iniziato | SunTrust | Hold |
| 2019-01-16 | Reiterato | Needham | Buy |
| 2018-03-08 | Reiterato | H.C. Wainwright | Buy |
| 2018-02-07 | Reiterato | Needham | Buy |
| 2017-12-05 | Reiterato | Needham | Buy |
| 2017-09-11 | Iniziato | H.C. Wainwright | Buy |
| 2017-05-11 | Reiterato | Needham | Buy |
| 2016-09-13 | Iniziato | Gabelli & Co | Buy |
| 2015-06-01 | Iniziato | Jefferies | Buy |
| 2015-06-01 | Iniziato | Needham | Buy |
| 2015-06-01 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Collegium Pharmaceutical Inc Borsa (COLL) Ultime notizie
Is Collegium Pharmaceutical Inc. a good long term investmentOutstanding capital appreciation - PrintWeekIndia
How high can Collegium Pharmaceutical Inc. stock price go in 2025Superior investment outcomes - jammulinksnews.com
Will Collegium Pharmaceutical Inc. stock split in the near futureFree Predictions - jammulinksnews.com
Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewswire
Will Collegium Pharmaceutical Inc. stock benefit from AI tech trendsOver 200% growth - jammulinksnews.com
Press Release: Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025 - 富途牛牛
Victory Capital Management Inc. Sells 60,823 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Bank of New York Mellon Corp Sells 10,426 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
What drives Collegium Pharmaceutical Inc. stock priceBreakthrough profit margins - jammulinksnews.com
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Bank of New York Mellon Corp - Defense World
What analysts say about Collegium Pharmaceutical Inc. stockLightning-fast capital gains - jammulinksnews.com
Collegium Pharmaceutical Inc. Stock Analysis and ForecastFree Stock Market Query - Autocar Professional
Teacher Retirement System of Texas Decreases Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Is Collegium Pharmaceutical Inc. stock a good hedge against inflationBreakout Confirmation Tool - Newser
What risks could impact Collegium Pharmaceutical Inc. stock performanceFree Investment Community - Newser
Unpacking Q1 Earnings: Organon (NYSE:OGN) In The Context Of Other Branded Pharmaceuticals Stocks - FinancialContent
What makes Collegium Pharmaceutical Inc. stock price move sharplyMassive Gain Ideas - Newser
How Collegium Pharmaceutical Inc. stock performs during market volatilityBalanced Risk Reward Portfolio - Newser
Why Collegium Pharmaceutical Inc. stock attracts strong analyst attentionMoney Making Low Risk Plans - Newser
(COLL) Technical Pivots with Risk Controls - news.stocktradersdaily.com
8,180 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Purchased by Allspring Global Investments Holdings LLC - Defense World
Collegium Pharmaceutical (COLL) Soars 1.98% on Strong Q1 Earnings - AInvest
Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 19% Impressive? - simplywall.st
Collegium announces $150M share repurchase program - MSN
Share Buyback Plan Authorized by Collegium Pharmaceutical (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2024 Earnings Call Transcript - MSN
Collegium Pharmaceutical authorizes $150 million share repurchase program By Investing.com - Investing.com Nigeria
Collegium Pharma Launches Up To $150 Mln Buyback Program; Stock Up In Pre-market - Nasdaq
Collegium Pharmaceutical authorizes $150 million share repurchase program - Investing.com
Collegium Announces $150 Million Share Repurchase Program - GlobeNewswire
COLL announces $150M share buyback through 2026 – cash-funded | COLL SEC FilingForm 8-K - Stock Titan
Collegium Expands Shareholder Returns With Fresh $150M Stock Buyback After Returning $222M Since 2021 - Stock Titan
Collegium Pharmaceutical Breaks Above 200-Day Moving AverageBullish for COLL - Nasdaq
Collegium Pharmaceutical Inc Azioni (COLL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.25%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):